Apex Medical Corporation has made its debut into Indian market with the launch of its three main product verticals - respiratory, support surface and autoclaves primarily as their core offering in India.
Apex Medical Corp is headquartered in Taiwan and founded in the year 1990. The company caters to Europe, United States, Asia and other international markets through an established network of international subsidiaries and partners. The company has a long term plan for the Indian market and will proceed in phases in a strategic manner.
The company has made its mark in the industry with its superlative, ultra advanced and innovative technological solutions. The company has a very strong R&D team that has driven innovation to continuously deliver world-class products. Apex invests 5 percent of its annual revenue on R&D. In coming few years, with an aggressive growth plan, Apex in India expects to grow at a CAGR of 30 per cent.
Apex’ s product verticals - respiratory, support surface and autoclaves launched in India are designed and developed as value products that will not only improve the patient’s well-being and but will also enhance the quality of life.
Taiwan is known for its technology prowess and Apex will bring technological excellence along with exceptional service support with an ease of affordability directly to the consumers in India.
Subscribe to PharmaTutor News Alerts by Email >>
